These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1213 related articles for article (PubMed ID: 32061014)

  • 1. Radiomics Based on Multimodal MRI for the Differential Diagnosis of Benign and Malignant Breast Lesions.
    Zhang Q; Peng Y; Liu W; Bai J; Zheng J; Yang X; Zhou L
    J Magn Reson Imaging; 2020 Aug; 52(2):596-607. PubMed ID: 32061014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of diffusion kurtosis imaging and quantitative dynamic contrast-enhanced MRI for the differentiation of breast tumors.
    Li T; Yu T; Li L; Lu L; Zhuo Y; Lian J; Xiong Y; Kong D; Li K
    J Magn Reson Imaging; 2018 Nov; 48(5):1358-1366. PubMed ID: 29717790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffusion Kurtosis at 3.0T as an in vivo Imaging Marker for Breast Cancer Characterization: Correlation With Prognostic Factors.
    Huang Y; Lin Y; Hu W; Ma C; Lin W; Wang Z; Liang J; Ye W; Zhao J; Wu R
    J Magn Reson Imaging; 2019 Mar; 49(3):845-856. PubMed ID: 30260589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiomics Nomogram Based on Dual-Sequence MRI for Assessing Ki-67 Expression in Breast Cancer.
    Zhang L; Shen M; Zhang D; He X; Du Q; Liu N; Huang X
    J Magn Reson Imaging; 2024 Sep; 60(3):1203-1212. PubMed ID: 38088478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of malignancy by a radiomic signature from contrast agent-free diffusion MRI in suspicious breast lesions found on screening mammography.
    Bickelhaupt S; Paech D; Kickingereder P; Steudle F; Lederer W; Daniel H; Götz M; Gählert N; Tichy D; Wiesenfarth M; Laun FB; Maier-Hein KH; Schlemmer HP; Bonekamp D
    J Magn Reson Imaging; 2017 Aug; 46(2):604-616. PubMed ID: 28152264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiparametric MRI model with dynamic contrast-enhanced and diffusion-weighted imaging enables breast cancer diagnosis with high accuracy.
    Zhang M; Horvat JV; Bernard-Davila B; Marino MA; Leithner D; Ochoa-Albiztegui RE; Helbich TH; Morris EA; Thakur S; Pinker K
    J Magn Reson Imaging; 2019 Mar; 49(3):864-874. PubMed ID: 30375702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoexponential, Biexponential, and stretched-exponential models using diffusion-weighted imaging: A quantitative differentiation of breast lesions at 3.0T.
    Jin YN; Zhang Y; Cheng JL; Zheng DD; Hu Y
    J Magn Reson Imaging; 2019 Nov; 50(5):1461-1467. PubMed ID: 30919518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate Cancer Differentiation and Aggressiveness: Assessment With a Radiomic-Based Model vs. PI-RADS v2.
    Chen T; Li M; Gu Y; Zhang Y; Yang S; Wei C; Wu J; Li X; Zhao W; Shen J
    J Magn Reson Imaging; 2019 Mar; 49(3):875-884. PubMed ID: 30230108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Machine Learning-Based Unenhanced Radiomics Approach to Distinguishing Between Benign and Malignant Breast Lesions Using T2-Weighted and Diffusion-Weighted MRI.
    Liu Y; Jia X; Zhao J; Peng Y; Yao X; Hu X; Cui J; Chen H; Chen X; Wu J; Hong N; Wang S; Wang Y
    J Magn Reson Imaging; 2024 Aug; 60(2):600-612. PubMed ID: 37933890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Classification of pulmonary lesion based on multiparametric MRI: utility of radiomics and comparison of machine learning methods.
    Wang X; Wan Q; Chen H; Li Y; Li X
    Eur Radiol; 2020 Aug; 30(8):4595-4605. PubMed ID: 32222795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bi-parametric magnetic resonance imaging based radiomics for the identification of benign and malignant prostate lesions: cross-vendor validation.
    Ji X; Zhang J; Shi W; He D; Bao J; Wei X; Huang Y; Liu Y; Chen JC; Gao X; Tang Y; Xia W
    Phys Eng Sci Med; 2021 Sep; 44(3):745-754. PubMed ID: 34075559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benign and malignant orbital lymphoproliferative disorders: Differentiating using multiparametric MRI at 3.0T.
    Xu XQ; Hu H; Liu H; Wu JF; Cao P; Shi HB; Wu FY
    J Magn Reson Imaging; 2017 Jan; 45(1):167-176. PubMed ID: 27299917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of Diffusion Kurtosis Imaging and Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Differentiating Benign and Malignant Head and Neck Lesions.
    Cheng J; Shao S; Chen W; Zheng N
    J Magn Reson Imaging; 2022 Feb; 55(2):414-423. PubMed ID: 34378259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Preoperative prediction of HER-2 expression status in breast cancer based on MRI radiomics model].
    Zhang Y; Huang H; Yin L; Wang ZX; Lu SY; Wang XX; Xiang LL; Zhang Q; Zhang JL; Shan XH
    Zhonghua Zhong Liu Za Zhi; 2024 May; 46(5):428-437. PubMed ID: 38742356
    [No Abstract]   [Full Text] [Related]  

  • 15. Preoperative prediction of lymphovascular invasion in invasive breast cancer with dynamic contrast-enhanced-MRI-based radiomics.
    Liu Z; Feng B; Li C; Chen Y; Chen Q; Li X; Guan J; Chen X; Cui E; Li R; Li Z; Long W
    J Magn Reson Imaging; 2019 Sep; 50(3):847-857. PubMed ID: 30773770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Breast MRI-based Radiomics for Distinguishing Benign and Malignant Lesions: An Analysis of Sequences and Enhanced Phases.
    Wang G; Guo Q; Shi D; Zhai H; Luo W; Zhang H; Ren Z; Yan G; Ren K
    J Magn Reson Imaging; 2024 Sep; 60(3):1178-1189. PubMed ID: 38006286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The outstanding diagnostic value of DKI in multimodal magnetic resonance imaging for benign and malignant breast tumors: A diagnostic accuracy study.
    Gao Y; Wang Y; Zhang H; Li X; Han L
    Medicine (Baltimore); 2023 Oct; 102(40):e35337. PubMed ID: 37800758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiating axillary lymph node metastasis in invasive breast cancer patients: A comparison of radiomic signatures from multiparametric breast MR sequences.
    Chai R; Ma H; Xu M; Arefan D; Cui X; Liu Y; Zhang L; Wu S; Xu K
    J Magn Reson Imaging; 2019 Oct; 50(4):1125-1132. PubMed ID: 30848041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiparametric MR Imaging Radiomics Signatures for Assessing the Recurrence Risk of ER+/HER2- Breast Cancer Quantified With 21-Gene Recurrence Score.
    Chen Y; Tang W; Liu W; Li R; Wang Q; Shen X; Gong J; Gu Y; Peng W
    J Magn Reson Imaging; 2023 Aug; 58(2):444-453. PubMed ID: 36440706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiomics-based machine learning analysis and characterization of breast lesions with multiparametric diffusion-weighted MR.
    Sun K; Jiao Z; Zhu H; Chai W; Yan X; Fu C; Cheng JZ; Yan F; Shen D
    J Transl Med; 2021 Oct; 19(1):443. PubMed ID: 34689804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 61.